Rimexolone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Rimexolone
Rimexolone structure.png
Systematic (IUPAC) name
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a606003
  • US: C (Risk not ruled out)
ocular
Identifiers
49697-38-3 YesY
H02AB12 S01BA13
PubChem CID 5311412
DrugBank DB00896 YesY
ChemSpider 4470902 N
UNII O7M2E4264D YesY
KEGG D05729 YesY
ChEMBL CHEMBL1200617 N
Chemical data
Formula C24H34O3
370.525 g/mol
 N (what is this?)  (verify)

Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.

References[edit]

  1. ^ Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.